Phosphotyrosine 1062 Is Critical for the In Vivo Activity of the Ret9 Receptor Tyrosine Kinase Isoform
ABSTRACT
The receptor tyrosine kinase Ret plays a critical role in the development of the mammalian excretory and enteric nervous systems. Differential splicing of the primary Ret transcript results in the generation of two main isoforms, Ret9 and Ret51, whose C-terminal amino acid tails diverge after tyrosine (Y) 1062. Monoisoformic mice expressing only Ret9 develop normally and are healthy and fertile. In contrast, animals expressing only Ret51 have aganglionosis of the distal gut and hypoplastic kidneys. By generating monoisoformic mice in which Y1062 of Ret9 has been mutated to phenylalanine, we demonstrate that this amino acid has a critical role in Ret9 signaling that is necessary for the development of the kidneys and the enteric nervous system. These findings argue that the distinct activities of Ret9 and Ret51 result from the differential regulation of Y1062 by C-terminal flanking sequences. However, a mutation which places Y1062 of Ret51 in a Ret9 context improves only marginally the ability of Ret51 to support renal and enteric nervous system development. Finally, monoisoformic mice expressing a variant of Ret9 in which a C-terminal PDZ-binding motif was mutated develop normally and are healthy. Our studies identify Y1062 as a critical regulator of Ret9 signaling and suggest that Ret51-specific motifs are likely to inhibit the activity of this isoform.
Top-30
Journals
1
2
3
4
5
|
|
Development (Cambridge)
5 publications, 7.04%
|
|
Developmental Biology
4 publications, 5.63%
|
|
Journal of Clinical Investigation
3 publications, 4.23%
|
|
Current Topics in Developmental Biology
3 publications, 4.23%
|
|
Scientific Reports
2 publications, 2.82%
|
|
Mechanisms of Development
2 publications, 2.82%
|
|
Journal of the American Society of Nephrology : JASN
2 publications, 2.82%
|
|
Organogenesis
2 publications, 2.82%
|
|
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 2.82%
|
|
Biology Open
1 publication, 1.41%
|
|
Circulation Research
1 publication, 1.41%
|
|
International Journal of Molecular Sciences
1 publication, 1.41%
|
|
Journal of Developmental Biology
1 publication, 1.41%
|
|
Frontiers in Physiology
1 publication, 1.41%
|
|
Frontiers in Molecular Neuroscience
1 publication, 1.41%
|
|
Nature Reviews Endocrinology
1 publication, 1.41%
|
|
Pediatric Surgery International
1 publication, 1.41%
|
|
Nature Medicine
1 publication, 1.41%
|
|
Pediatric Nephrology
1 publication, 1.41%
|
|
Pituitary
1 publication, 1.41%
|
|
Nature Clinical Practice Oncology
1 publication, 1.41%
|
|
Nature Reviews Cancer
1 publication, 1.41%
|
|
Cell and Tissue Research
1 publication, 1.41%
|
|
Nature Reviews Neuroscience
1 publication, 1.41%
|
|
Seminars in Pediatric Surgery
1 publication, 1.41%
|
|
PLoS Genetics
1 publication, 1.41%
|
|
American Journal of Human Genetics
1 publication, 1.41%
|
|
Endocrinology and Metabolism Clinics of North America
1 publication, 1.41%
|
|
Seminars in Nephrology
1 publication, 1.41%
|
|
1
2
3
4
5
|
Publishers
2
4
6
8
10
12
14
16
18
|
|
Elsevier
17 publications, 23.94%
|
|
Springer Nature
13 publications, 18.31%
|
|
The Company of Biologists
6 publications, 8.45%
|
|
Wiley
5 publications, 7.04%
|
|
American Society for Clinical Investigation
3 publications, 4.23%
|
|
Taylor & Francis
3 publications, 4.23%
|
|
MDPI
2 publications, 2.82%
|
|
Frontiers Media S.A.
2 publications, 2.82%
|
|
American Society of Nephrology
2 publications, 2.82%
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 2.82%
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.41%
|
|
Public Library of Science (PLoS)
1 publication, 1.41%
|
|
Oxford University Press
1 publication, 1.41%
|
|
Cambridge University Press
1 publication, 1.41%
|
|
Japan Academy
1 publication, 1.41%
|
|
Hindawi Limited
1 publication, 1.41%
|
|
American Association for Cancer Research (AACR)
1 publication, 1.41%
|
|
American Physiological Society
1 publication, 1.41%
|
|
eLife Sciences Publications
1 publication, 1.41%
|
|
Annual Reviews
1 publication, 1.41%
|
|
Cold Spring Harbor Laboratory
1 publication, 1.41%
|
|
IntechOpen
1 publication, 1.41%
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.